Putnam BioRevolution ETF (SYNB)

Assets	$5.47M
Expense Ratio	0.70%
PE Ratio	26.76
Shares Out	175,000
Dividend (ttm)	n/a
Dividend Yield	n/a
Ex-Dividend Date	n/a
Payout Ratio	n/a
1-Year Return	+9.94%

Volume	5
Open	32.09
Previous Close	31.10
Day's Range	30.98 - 32.22
52-Week Low	24.47
52-Week High	32.22
Beta	1.00
Holdings	35
Inception Date	Sep 29, 2022

About SYNB

Fund Home Page

The Putnam BioRevolution ETF (SYNB) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund actively invests in companies of all sizes around the globe that enable biological innovation. SYNB was launched on Sep 29, 2022 and is issued by Putnam.

• Asset Class: Equity
• Stock Exchange: NYSEARCA
• Ticker Symbol: SYNB
• ETF Provider: Putnam

Top 10 Holdings

53.65% of assets

Name	Symbol	Weight
NVIDIA Corporation	NVDA	7.98%
Thermo Fisher Scientific Inc.	TMO	7.45%
Danaher Corporation	DHR	7.21%
Bio-Rad Laboratories, Inc.	BIO	5.36%
Alphabet Inc.	GOOGL	5.20%
Novonesis AS ADR	NVZMY	4.58%
Corteva, Inc.	CTVA	4.49%
Regeneron Pharmaceuticals, Inc.	REGN	3.83%
Eli Lilly and Company	LLY	3.78%
AbbVie Inc.	ABBV	3.77%

Dividends

Ex-Dividend	Amount	Pay Date
Dec 6, 2023	$0.0211	Dec 11, 2023